|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1133 S.W. Topeka Blvd. |
Address2 |
|
City | Topeka |
State | KS |
Zip Code | 66629-0001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 323876-12
|
||||||||
|
6. House ID# 397350000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Sunee Mickle |
Date | 7/20/2020 6:07:38 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Care Reform; Rural Healthcare; Risk Adjustment; CSRs; Opioids; Marketplace Stability; Individual Market Reform; Association Health Plans (AHPs); Value-Based Reimbursement; Health Care Costs; Mental Health; Reinsurance; Transparency; Silverloading; Interoperability; Health IT; Surprise Billing; Small Business; Prior Authorization; Provider Directories; Health Reimbursement Arrangements (HRAs); Education and Enrollment; Consumer-facing app disclosures; Negotiated Rate Disclosure; Medicare for All; Medicare Buy-In, Social determinants of health, Community Health, Cybersecurity, NBPP(Notice Benefit and Payment Parameters);Provider directories; Maternal Health; Senior's health care; COVID-19 Response/Relief Packages; Healthcare access/privacy; Risk Corridors; COBRA; Telehealth; SEPs; CDC Guidance Testing; Safe Harbor; Prior Authorizations; COVID-19 Test Without Cost-Sharing.
H.R. 1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7](Introduced 2/27/19)
S. 1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN](Introduced 6/19/2019)
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr [D-NJ-6](Introduced 07/09/2019)
H.R.3439 - 116th Congress (2019-2020)
PATIENT Act
Sponsor: Rep. Beyer, Donald S.,Jr. [D-VA-8](Introduced 06/24/2019)
S. 2546 - 116th Congress (2019-2020)
Safe Step Act
Sponsor: Sen. Lisa Murkowshi (R-Ark)
H.R.5826 - 116th Congress (2019-2020)
Consumer Protections Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Neal, Richard [D-MA-1] (Introduced 02/10/2020)
S.3548 - 116th Congress (2019-2020)
Coronavirus Aid, Relief, and Economic Security Act
Sponsor: Sen. McConnell, Mitch [R-KY](Introduced 03/19/2020)
H.R.5754 - 116th Congress (2019-2020)
Rural ER Access Act
Sponsor: Rep. Green, Mark [R-TN-7](Introduced 02/04/2020)
H.R. 5763 - 116th Congress - Second Session
National Telehealth Strategy and Data Advancement Act
Sponsor: Rep. Greg Gianforte (R-MT At-Large)
H.R.5800 - 116th Congress (2019-2020)
Ban Surprise Billing Act
Sponsor: Rep. Scott, Robert [D-VA-3](Introduced 02/07/2020)
H.R.5916 - 116th Congress (2019-2020)
Transparent Health Care PRicing Act of 2020
Sponsor: Rep. Mike Gallagher (R-WI-08)
Public Law 116-127 (H.R.6201) - 116th Congress - Second Session
First Coronavirus Response Act
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6336 - 116th congress - Second Session
To amend title XI of the Social Security Act to provide for a waiver of payment reductions under the Medicare and Medicaid programs for certain nonapproved capital expenditures undertaken by health care facilities during the COVID-19 emergency.
Sponsor: Rep. Dan Bishop (R-NC_09)
H.R. 6311 - 116th Congress - Second Session
Care for COVID-19 Act
Sponsor: Rep. Raul Ruiz (D-CA-36)
H.R. 6299 - 116th COngress - Second Session
Rapid COverage of COVID-19 Vaccine Act of 2020
H.R. 5816 - 116th Congress - Second Session
Continuing Care for Patients Act of 2020
Sponsor: Rep. Gwen Moore (D-WI-04)
H.R. 5826 - 116th Congress Second Session
Consumer Protections Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Richard Neal (D-MA-01)
H.R. 5924 - 116th Congress Second Session
To amend the Public Health Service Act to authorize a loan repayment program to encourage specialty medicine physicians to serve in rural communities experiencing a shortage of specialty medicine physicians, and for other purposes.
Sponsor: Rep. David McKinley (R-WV-01)
H.R. 6004 - 116th Congress - Second Session
Transparency and Accountability in Health Care Costs and Prices Act of 2020
Sponsor: Rep. Dan Lipinski (D-IL-03)
H.R. 6173 - 116th Congress - Second Session
Covering Coronavirus Test Act of 2020
Sponsor: Rep. Diana DeGette (D-CO-01)
H.R. 6213 - 116th Congress - Second Session
No Cost for COVID-19 Testing Act
Sponsor: Rep. Frederica Wilson (D-FL-24)
H.R. 6222 - 116th Congress - Second Session
Ensuring Affordable COVID-19 Preventative Care Act of 2020
Sponsor: Rep. Jan Schakowsky (D-IL-09)
H.R. 6232 - 116th Congress - Second Session
To require the SEcretary of Health and Human Services, through the National Desaster Medicdal System, to provide for certain laboratory reimbursement for diagnostic testing for COVID-19 in uninsured individuals.
Sponsor: Rep Tony Cardenas (D-CA-29)
H.R. 6231 - 116th Congress - Second Session
Ensuring Access to COVID-19 Preventative Care Act of 2020
Sponsor: Rep. Larry Bucshon (R-IN-08)
H.R. 6263 - 116th Congress - Second Session
To amend title XVIII of the Social Security Acto to waive cost sharing under the Medicare program for certain visits relating to testing for COVID-19.
Sponsor: Rep. John Sarbanes (D-MD-03)
H.R. 6810 - 116th Congress - Second Session
Health Care Protection Act
Sponsor: Rep. Rodney Davis (R-IL-13)
Public Law 116-123 (H.R. 6074) - 116th Congress - Second Session
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6800 - 116th Congress - Second Session
HEROES Act
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6338 - 116th Congress - Second Session
Pandemic Healthcare Access Act
Sponsor: Rep. Ted Budd (R-NC-13)
H.R. 5808 - 116th Congress - Second Session
Save Rural Communities Act of 2020
Sponsor: Rep. Jodey Arrington (R-TX-19)
H.R. 7391 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to remove certain geographic and originating site restrictions on the furnishing of telehealth services under the Medicare program.
H.R. 5763 - 116th Congress - Second Session
National Telehealth Strategy and Data Advancement Act
Sponsor: Greg Gianforte (R-MT At-Large)
H.R. 6792 - 116th Congress - Second Session
Improving Telehealth for Underserved Communities Act of 2020
Sponsor: Rep. Adrian Smith (R-NE-03)
H.R. 6918 - 116th Congress - Second Session
Paycheck Recovery Act of 2020
Sponsor: Rep. Pramila Jayapal (D-WA-07)
Public Law - 116-136 (H.R.748) - 116th Congress - First Session
Third Coronavirus Stimulus Package
Sponsor: Rep. Joe Courtney (D-CT-02)
H.R. 3107 - 116th Congress
Improving Senior's Timely Access to Care Act of 2019
Sponsor: Rep. Suzan DelBene (D-WA), Rep. Mike Kelly (R-PA), Rep. Roger Marshal (R-KS0 and Ami Bera (D-CA)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sunee |
Mickle |
|
Vice President of Government and Community Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Advantage; Medicaid Expansion; Medicare Data Sharing; Privacy; Medicare Prescription Drug Pricing; CMS; Generic drugs (CREATES); MACRA; Drug approval; Provider funding; Coronavirus Medicaid Response; Rate Notice and Call Letter; Prior Authorizations, COVID-19 Test Without Cost-Sharing.
H.R. 3107 - 116th Congress (2019-2020)
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. Suzan DelBene (D-WA), Rep. Mike Kelly (R-PA), Roger Marshal (R-KS) and Ami Bera (D-CA)
H.R. 5833 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to permit the use of certain psychological evaluation via telehealth for Medicare coverage of neurostimulation services for the treatment of chronic pain.
Sponsor: Rep. Bob Latta (R-OK-05)
H.R. 6179 - 116th Congress - Second Session
Increasing Access to Biosimilars Act of 2020
Sponsor: Rep. Tony Cardenas (D-CA-29)
H.R. 6218 - 116th Congress - Second Session
Preserving Patient Access to Home INfusion Act
Sponsor: Rep. Eliot Engel (D-NY-16)
H.R. 6214 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to provide for coverage of testing for COVID-19 at no cost sharing under the Medicare Advantage program.
Sponsor: Rep. Ron Kind (D-WI-03)
H.R. 6484 - 116th Congress - Second Session
Care for COVID-19 Act 2.0
Sponsor: Rep. Raul Ruiz (D-CA-36)
H.R. 6674 - 116th Congress - Second Session
Medicare Crisis Program Act of 2020
Sponsor: Rep. Pramila Hayapal. (D-WA-07)
H.R. 6739 - 116th Congress - Second Session
Ensuring Seniors' Access to COVID Treatments Act
Sponsor: Rep. Sean Casten (D-IL-06)
H.R. 7062 - 116th Congress - Second Session
Affordable Insulin for the COVID-19 Emergency Act
Sponsor: Rep. Maxine Waters (D-CA-43)
H.R. 6583 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to establish a risk corridor program for Medicare Advantage plans during the COVID-19 emergency, and for other purposes.
Sponsor: Rep. Chrissy Houlahan (D-PA-06)
H.R. 6640 - 116th Congress - Second Session
Medicare Advantage COVID Treatment Act
Sponsor: Rep. Debbie Mucarsel-Powell (D-FL-26)
H.R. 6837 - 116th Congress - Second Session
Medicare Accelerated and Advance Payments IMprovement Act of 2020
Sponsor: Rep. Brad Schneider (D-IL-10)
H.R. 7292 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to provide for forgiveness of certain accelerated and advance payments under parts A and B of the Medicare program.
Sponsor: Repm. Marcy Kaptur (D-OH-09)
H.R. 7323 - 116th Congress - Second Session
Medicare Mental Health Inpatient Equity Act of 2019
Sponsor: Rep. Paul Tonko (D-NY-20)
H.R. 7338 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to permit the Secretary of Health and Human Services to waive requirements relating to the furnishing of telehealth services under the Medicare program, and for other purposes.
Sponsor: Rep. Liz Cheney (R-WY-At-Large)
H.R. 5883 - 116th Congress - Second Session
Generating Effective and Novel Evidence for Therapy Payment Act
Sponsor: Rep. Kurt Schrader (D-OR-05)
H.R. 6649 - 116th Congress - Second Session
Lower Drug Costs for Seniors During COVID-19 Act of 2020
Sponsor: Rep. Jan Schakowsky (D-IL-09)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sunee |
Mickle |
|
Vice President of Government and Community Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Health Insurance Tax (HIT Tax); Tax Extenders; ACA tax credits
H.R.748 - 116th Congress (2019-2020)
Third Coronavirus Stimulus Package (CARES Act)
To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
H.R. 3107 - 116th Congress
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. Suzan DelBene(D-WA), Rep. Mike Kelly (R-PA), Roger Marshal (R-KS), and Ami Bera (D-CA)
H.R. 6440 - 116th Congress - Second Session
Pandemic Rapid Response Act
Sponsor: Rep. Rodney Davis (R-IL-13)
H.R. 6396 - 116th Congress - Second Session
Responsible Relief for Americans Act
Sponsor: Rep. Andy Biggs (R-AZ-05)
H.R. 6286 - 116th Congress - Second Session
Health Savings Act of 2020
Sponsor: Rep. mike Burgess (R-TX-26)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sunee |
Mickle |
|
Vice President of Government and Community Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Opioids; CREATES Act; Drug Pricing
H.R.6193 - 116th Congress
Medication Access in Emergencies Act of 2020
Sponsor: Rep Pappas, Chris [D-NH-1]
H.R.5691 - 116th Congress
Transparency in Prescription Drug Advertising Act
Sponsor: Rep Davids, Sharice [D-KS-3]
H.R. 5894 - 116th Congress - Second Session
Insulin Affordability Data Collection Act
H.R. 5894 - 116th Congress - Second Session
Transparency in Prescription Drug Advertising Act
Sponsor: Rep. Sharice Davids (D-KS-03)
H.R. 5927 - 116th Congress - Second Session
Safe Medicine Act
Sponsor: Rep. Bill Posey (R-FL-08)
H.R. 5663 - 116th Congress - Second Session
Safeguarding Therapeutics Act
Sponsor: Rep Brett Guthrie (R-KY-02)
H.R. 2477 - 116th Congress
Beneficiary Enrollment Notification and Eligibility Simplification Act of 2019
Sponsor: Rep. Raul Ruiz (D-CA-36)
H.R. 5749 - 116th Congress - Second Session
Affordable Insulin for All Act
Sponsor: Rep. Charlie Crist (D-FL-13)
H.R. 6731 - 116th Congress - Second Session
Securing America's Pharmaceutical Supply Chain Act
Sponsor: Rep. Pete Stauber (R-MN-08)
H.R. 5982 - 116th Congress - Second Session
Safe Medicine Act
Sponsor: Rep. Bill Posey (R-FL-08)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sunee |
Mickle |
|
Vice President of Government and Community Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |